ScreenerHero

0QQJ EvoNext Holdings SA

LSE · GB · Healthcare · Biotechnology · evonextholdings.com
2.210CHF+3.27%Mkt Cap: —P/E: —

EvoNext Holdings SA is in the process of liquidation of its remaining assets. Previously, the company was engaged in discovery, research, development, and commercialization of nature-based ingredients for use in flavor a…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap—
Enterprise Value11.93M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-1.06M USD
Revenue/Share—
Last Price2.210 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B3.00
EPS (TTM)-0.05
EPS (Forward)—
52W Range
0.750074% of range2.730
52W High2.730 CHF
52W Low0.7500 CHF
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-16.06%
ROA-9.00%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.39M USD
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-6.26M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio21.10
Quick Ratio20.94
Book Value/Sh0.74 CHF
Cash/Share0.76 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CHF
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split0.004:1
Split DateApr 26, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.734.31M
Float—
Insiders41.00%
Institutions3.45%
Technical
SMA 500.7013 (+215.1%)
SMA 2004.232 (-47.8%)
Beta-0.05
S&P 52W Chg15.78%
Avg Vol (30d)1.81K
Avg Vol (10d)1.21K
Technical Indicators
RSI (14)52.1
MACD-0.0035
MACD Signal0.0129
MACD Hist.-0.0164
BB Upper2.498 CHF
BB Middle2.221 CHF
BB Lower1.944 CHF
BB Width24.94%
ATR (14)0.1014 CHF
Vol Ratio (20d)0.00x